The European Medicines Agency (EMA) said on Thursday that the agency's safety committee will convene a meeting on March 29 to continue discussions on cases of blood clots related to AstraZeneca COVID-19 vaccine.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3